Friday, April 7, 2017

Germany's Fresenius in talks to buy generic drugmaker Akorn

(Reuters) - German healthcare group Fresenius SE & Co KGaA said on Friday that it was in talks with the generic drugmaker Akorn Inc for a potential takeover.

Read more

No comments:

Post a Comment